Loading provider…
Loading provider…
Hematology & Oncology Physician in Goodyear, AZ
NPI: 1548246655Primary Employer
City of Hope Cancer Center Phoenix
cityofhope.org
HQ Phone
Get M.D. Alan's Phone NumberMobile
Get M.D. Alan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
CA State Medical License
AZ State Medical License
CA State Medical License
2009
UT State Medical License
2025 - 2028
AZ State Medical License
2011 - 2027
CO State Medical License
2025 - 2027
MN State Medical License
2004 - 2009

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Residency • Internal Medicine
2003 - 2006
Fellowship • Hematology and Medical Oncology
2006 - 2009
David Geffen School of Medicine at UCLA
medschool.ucla.edu
BS • Biochemistry
1994 - 1998
Chicago Medical School at Rosalind Franklin University of Medicine and Science
Medical School
Until 2003
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 110 | 131 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 44 | 59 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 41 | 43 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 24 | 24 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 12 | 12 |
DNA Repair and Prostate Cancer: A Field Ripe for Harvest.
Authors: Bryce, Alan H, Sartor, Oliver, de Bono, Johann
Journal: Eur Urol
Publication Date: 2020-07-05
Lead Sponsor: Masonic Cancer Center, University of Minnesota
Intervention / Treatment: DRUG: Carboplatin, DRUG: Prednisone, DRUG: Cabazitaxel, DRUG: Abiraterone
Lead Sponsor: GRAIL, Inc.
Lead Sponsor: Clarity Pharmaceuticals Ltd
Intervention / Treatment: DRUG: 64Cu-SAR-bisPSMA, DRUG: 67Cu-SAR-bisPSMA